Bright Minds Biosciences (DRUG) Short Interest Ratio & Short Volume $24.36 -1.29 (-5.03%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$25.20 +0.84 (+3.47%) As of 07:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bright Minds Biosciences Short Interest DataBright Minds Biosciences (DRUG) has a short interest of 164,700 shares, representing 3.34% of the float (the number of shares available for trading by the public). This marks a 90.63% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.4, indicating that it would take 4.4 days of the average trading volume of 823,079 shares to cover all short positions.Current Short Interest164,700 sharesPrevious Short Interest86,400 sharesChange Vs. Previous Month+90.63%Dollar Volume Sold Short$4.30 millionShort Interest Ratio4.4 Days to CoverLast Record DateJune 30, 2025Outstanding Shares7,040,000 sharesFloat Size4,930,000 sharesShort Percent of Float3.34%Today's Trading Volume22,316 sharesAverage Trading Volume823,079 sharesToday's Volume Vs. Average3% Short Selling Bright Minds Biosciences? Sign up to receive the latest short interest report for Bright Minds Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartDRUG Short Interest Over TimeDRUG Days to Cover Over TimeDRUG Percentage of Float Shorted Over Time Bright Minds Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2025164,700 shares $4.30 million +90.6%3.3%4.4 $26.11 6/15/202586,400 shares $2.38 million +8.5%1.8%3.1 $27.58 5/31/202579,600 shares $2.07 million -0.9%1.6%2.6 $26.00 5/15/202580,300 shares $2.60 million -7.5%1.6%2.3 $32.36 4/30/202586,800 shares $2.66 million -0.1%1.8%2.2 $30.70 4/15/202586,900 shares $2.82 million -12.8%1.8%1.7 $32.41 3/31/202599,700 shares $3.60 million -8.2%2.0%1.6 $36.07 3/15/2025108,600 shares $3.89 million +0.8%2.2%1.6 $35.78 2/28/2025107,700 shares $4.01 million -14.8%2.2%1.4 $37.24 2/15/2025126,400 shares $5.28 million -8.2%2.6%1.2 $41.80 Get the Latest News and Ratings for DRUG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025137,700 shares $4.68 million -19.9%2.7%1 $34.00 1/15/2025172,000 shares $6.18 million -2.7%3.4%0.6 $35.92 12/31/2024176,700 shares $6.36 million -20.1%3.5%0.1 $36.02 12/15/2024221,200 shares $9.07 million -0.1%4.4%0.1 $41.00 11/30/2024221,400 shares $9.74 million -16.4%4.4%0.1 $44.00 11/15/2024264,800 shares $10.49 million -17.9%5.2%0.1 $39.61 10/31/2024322,600 shares $15.10 million -72.4%11.7%0.1 $46.80 10/15/20241,170,000 shares $45.03 million +1,274.9%38.2%0.4 $38.49 9/30/202485,100 shares $99.57 thousand -19.6%3.0%0.8 $1.17 9/15/2024105,900 shares $135.02 thousand -41.7%3.7%1 $1.28 8/31/2024181,500 shares $192.39 thousand +149.7%6.3%1.8 $1.06 8/15/202472,700 shares $74.88 thousand +0.6%2.5%0.8 $1.03 7/31/202472,300 shares $83.87 thousand +3.6%2.5%3.4 $1.16 7/15/202469,800 shares $71.20 thousand -2.0%2.4%3 $1.02 6/30/202471,200 shares $77.22 thousand -0.4%2.5%6 $1.08 6/15/202471,500 shares $75.08 thousand -13.5%2.5%4.5 $1.05 5/31/202482,700 shares $100.07 thousand +17.5%2.9%4.4 $1.21 5/15/202470,400 shares $76.38 thousand No Change2.5%3.6 $1.09 4/30/202470,400 shares $70.40 thousand -7.0%2.6%3.3 $1.00 4/15/202475,700 shares $93.11 thousand +7.2%2.8%3.1 $1.23 3/31/202470,600 shares $84.71 thousand -3.6%2.6%2.5 $1.20 3/15/202473,200 shares $95.16 thousand +3.1%2.7%2.2 $1.30 2/29/202471,000 shares $127.80 thousand +0.3%2.6%2 $1.80 2/15/202470,800 shares $138.76 thousand -0.4%2.5%1.9 $1.96 1/31/202471,100 shares $151.44 thousand -9.1%2.9%2 $2.13 1/15/202478,200 shares $151.01 thousand +7.6%3.2%2.6 $1.93 12/31/202372,700 shares $103.96 thousand -5.6%3.0%2.4 $1.43 12/15/202377,000 shares $115.50 thousand -9.4%3.0%3.3 $1.50 11/30/202385,000 shares $113.90 thousand +21.6%3.3%3.6 $1.34 11/15/202369,900 shares $88.77 thousand -1.4%2.7%2.3 $1.27The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.Now he's identified his next potential winner. Click here to find out more. 10/31/202370,900 shares $95.72 thousand -1.3%2.7%1.1 $1.35 10/15/202371,800 shares $112.01 thousand -1.0%2.8%0.1 $1.56 9/30/202372,500 shares $116 thousand -1.0%2.8%0.1 $1.60 9/15/202373,200 shares $114.92 thousand -12.8%2.8%0.1 $1.57 8/31/202383,900 shares $180.39 thousand -50.7%3.2%0.1 $2.15 8/15/2023170,200 shares $451.03 thousand +49.3%6.6%0.3 $2.65 7/31/2023114,000 shares $474.24 thousand +16.9%4.4%0.2 $4.16 7/15/202397,500 shares $358.80 thousand -80.7%3.8%0.9 $3.68 6/30/2023505,400 shares $1.44 million -7.5%3.8%0.7 $2.85 6/15/2023546,300 shares $319.69 thousand -19.8%4.1%0.8 $0.59 5/31/2023680,900 shares $427.06 thousand +15.9%4.8%1 $0.63 5/15/2023587,600 shares $317.30 thousand -13.0%4.1%0.9 $0.54 4/30/2023675,000 shares $424.37 thousand +38.2%4.7%1 $0.63 4/15/2023488,600 shares $200.28 thousand +2.2%3.4%0.7 $0.41 3/31/2023478,100 shares $210.41 thousand -0.1%3.4%3.7 $0.44 3/15/2023478,500 shares $229.68 thousand +0.8%3.4%2.8 $0.48 2/28/2023474,800 shares $273.60 thousand -22.4%3.3%2.5 $0.58 2/15/2023612,100 shares $448.67 thousand +4.3%4.4%2.8 $0.73 1/31/2023586,900 shares $422.16 thousand +11.6%4.2%2.2 $0.72 1/15/2023525,700 shares $415.30 thousand -21.8%3.8%1.9 $0.79 12/30/2022672,200 shares $497.43 thousand -17.9%4.9%1.1 $0.74 12/15/2022818,500 shares $746.88 thousand -0.8%8.3%1.2 $0.91 11/30/2022824,900 shares $899.14 thousand -11.6%11.0%0.6 $1.09 11/15/2022932,900 shares $918.91 thousand +23.0%12.5%0.1 $0.99 10/31/2022758,600 shares $751.01 thousand +58.5%10.1%0.1 $0.99 10/15/2022478,500 shares $435.48 thousand +34.6%6.4%0 $0.91 9/30/2022355,600 shares $437.39 thousand -24.6%4.9%0 $1.23 9/15/2022471,600 shares $603.65 thousand -58.6%6.5%0 $1.28 8/31/20221,140,000 shares $2.19 million +1,809.6%16.3%0.1 $1.92 8/15/202259,700 shares $59.54 thousand +64.9%0.9%0 $1.00 7/31/202236,200 shares $36.02 thousand +10.0%0.5%0.6 $1.00 7/15/202232,900 shares $28.04 thousand +56.7%0.5%0.6 $0.85 6/30/202221,000 shares $16.79 thousand -56.3%0.3%0.4 $0.80 6/15/202248,100 shares $44.41 thousand +2.3%0.7%0.6 $0.92 5/31/202247,000 shares $51.70 thousand +144.8%0.7%0.5 $1.10 5/15/202219,200 shares $18.72 thousand -28.9%0.3%0.2 $0.98 4/30/202227,000 shares $25.25 thousand -26.0%0.4%0.3 $0.94 4/15/202236,500 shares $47.00 thousand -21.3%0.6%0.5 $1.29 3/31/202246,400 shares $70.39 thousand +29.3%0.7%0.8 $1.52 3/15/202235,900 shares $55.65 thousand -29.1%0.6%0.9 $1.55 2/28/202250,600 shares $105.75 thousand +13.7%0.8%3.6 $2.09 2/15/202244,500 shares $107.69 thousand -11.9%0.7%2.2 $2.42 1/31/202250,500 shares $122.72 thousand +6.3%0.7%0.3 $2.43 1/15/202247,500 shares $135.85 thousand +43.5%0.7%0.3 $2.86 12/31/202133,100 shares $104.93 thousand No Change0.5%0.2 $3.17 DRUG Short Interest - Frequently Asked Questions What is Bright Minds Biosciences' current short interest? Short interest is the volume of Bright Minds Biosciences shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 164,700 shares of DRUG short. 3.34% of Bright Minds Biosciences' shares are currently sold short. Learn More on Bright Minds Biosciences' current short interest. What is a good short interest ratio for Bright Minds Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DRUG shares currently have a short interest ratio of 4.0. Learn More on Bright Minds Biosciences's short interest ratio. What is a good short interest percentage for Bright Minds Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.34% of Bright Minds Biosciences' floating shares are currently sold short. Is Bright Minds Biosciences' short interest increasing or decreasing? Bright Minds Biosciences saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 164,700 shares, an increase of 90.6% from the previous total of 86,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Bright Minds Biosciences' float size? Bright Minds Biosciences currently has issued a total of 7,040,000 shares. Some of Bright Minds Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bright Minds Biosciences currently has a public float of 4,930,000 shares. How does Bright Minds Biosciences' short interest compare to its competitors? 3.34% of Bright Minds Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bright Minds Biosciences: Avid Bioservices, Inc. (18.17%), uniQure N.V. (16.74%), CorMedix Inc (15.02%), Cronos Group Inc. (1.43%), GH Research PLC (6.71%), Syndax Pharmaceuticals, Inc. (28.93%), Immunome, Inc. (16.38%), Gyre Therapeutics, Inc. (11.07%), Vir Biotechnology, Inc. (6.45%), Ginkgo Bioworks Holdings, Inc. (31.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Bright Minds Biosciences stock? Short selling DRUG is an investing strategy that aims to generate trading profit from Bright Minds Biosciences as its price is falling. DRUG shares are trading down $1.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bright Minds Biosciences? A short squeeze for Bright Minds Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DRUG, which in turn drives the price of the stock up even further. How often is Bright Minds Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRUG, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies CDMO Short Interest QURE Short Interest CRMD Short Interest CRON Short Interest GHRS Short Interest SNDX Short Interest IMNM Short Interest GYRE Short Interest VIR Short Interest DNA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DRUG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bright Minds Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bright Minds Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRUG Stock Alerts